Financial incentives to increase engagement across the hepatitis C care cascade among people at risk of or diagnosed with hepatitis C: A systematic review.
Shen C, Dawe J, Traeger MW, Sacks-Davis R, Pedrana AE, Doyle JS, Hellard ME, Stoové M
Hepatitis C Injecting Drug Use
Long-term outcomes of a decentralized, nurse-led, statewide model of care for hepatitis C among people in prison in Victoria, Australia.
MacIsaac MB, Papaluca T, McDonald L, Craigie A, Edwards A, Layton C, Gibson A, Winter RJ, Iyer K, Sim A, Evans S, Kumaragama K, Howell J, Desmond P, Iser D, Scott N, Hellard M, Stoové M, Wilson D, Pedrana A, Doyle JS, Holmes JA, Thompson AJ.
Hepatitis C Injecting Drug Use Justice Health
Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocol.
Doyle JS, Heath K, Elsum I, Douglass C, Wade A, Kasza J, Allardice K, Von Bibra S, Chan K, Camesella B, Guzman R, Bryant M, Thompson AJ, Stoové MA, Snelling TL, Scott N, Spelman T, Anderson D, Richmond J, Howell J, Andric N, Dietze PM, Higgs P, Sacks-Davis R, Forbes AB, Hellard ME, Pedrana AE
Hepatitis C
Evaluation of a Project Integrating Financial Incentives into a Hepatitis C Testing and Treatment Model of Care at a Sexual Health Service in Cairns, Australia, 2020-2021.
Dawe J, Gorton C, Lewis R, Richmond JA, Wilkinson AL, Pedrana A, Stoové M, Doyle JS, Russell D
Hepatitis C Injecting Drug Use
What Lies Beneath? The Role of Community Engagement in Translating COVID-19 Research Findings to Policy-Makers.
Merner B, Hill S, Saich F, Virgona A, Jin D, Pedrana A, Keren C, Chung RKY, Osborne D, Wilkinson AL, Coelho A, Gibbs L, Gibney KB, Hellard M, Lusher D, Ryan R
COVID-19
Innovation is needed to increase viral hepatitis testing globally.
Hellard ME, Pedrana A.
Hepatitis B Hepatitis C